A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with around 9% of patients surviving >5 years. Asymptomatic in its initial stages, PDAC is mostly diagnosed late, when already a locally advanced or metastatic disease, as there are no useful biomarkers for detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Debernardi, Silvana, O’Brien, Harrison, Algahmdi, Asma S., Malats, Nuria, Stewart, Grant D., Plješa-Ercegovac, Marija, Costello, Eithne, Greenhalf, William, Saad, Amina, Roberts, Rhiannon, Ney, Alexander, Pereira, Stephen P., Kocher, Hemant M., Duffy, Stephen, Blyuss, Oleg, Crnogorac-Jurcevic, Tatjana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758047/
https://www.ncbi.nlm.nih.gov/pubmed/33301466
http://dx.doi.org/10.1371/journal.pmed.1003489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758047/
https://www.ncbi.nlm.nih.gov/pubmed/33301466
http://dx.doi.org/10.1371/journal.pmed.1003489

Ejemplares similares